News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

NIH Funds Nine Anti-Microbial Resistance Diagnostic Projects to Deal with ‘Super Bugs’ and Give Clinical Laboratories New Diagnostic Tools to Improve Patient Care

Lab-on-a-chip technology could reduce the time needed to identify infection-causing bacteria and for physicians to prescribe correct antibiotics 

Pathology groups and medical laboratories may see their role in the patient-care process grow if researchers succeed in developing culture-independent diagnostic tools that quickly identify bacterial infections as well as pinpoint the antibiotics needed to treat them.

In the battle against antibiotic-resistant infections (AKA “super bugs”) the National Institutes of Health (NIH) is funding nine research projects aimed at thwarting the growing problem of life-threatening infections that no longer are controlled or killed by today’s arsenal of drugs.

Common Practices in Hospitals Leading to Super Bugs

Currently, when infections are suspected in hospitals or other settings where illness can quickly spread, samples are sent to a central medical laboratory where it may take up to three days to determine what germ is causing the infection. Because of that delay, physicians often prescribe broad-spectrum antibiotics based on a patient’s symptoms rather than lab test results, a practice that can lead to the growth of antibiotic-resistant microbes. (more…)

Researchers at Livermore National Laboratory Develop Microbial Detection Array Capable of Detecting Thousands of Known and Unknown Pathogens in a Single Rapid Test

Developed to detect pathogens missed in wounds of soldiers, this technology was licensed to a company for development into a test for use by clinical laboratories

Diagnostic technology developed for rapid detection of pathogens in the wounds of soldiers has been licensed to a private company that intends to use it to create new medical laboratory tests. This new technology is capable of identifying thousands of bacteria and viruses in a single test.

Scientists at the Lawrence Livermore National Laboratory developed what is called the Lawrence Livermore Microbial Detection Array (LLMDA). Within 24 hours, this single test can detect multiple viruses and bacteria. The LLMDA technology has been licensed to St. Louis, Missouri-based MOgene LC, a supplier of DNA microarrays, according to a report published by UC Health. (more…)

John Hopkins Researchers Demonstrate Hydrogen Peroxide’s Effectiveness in Preventing HAIs, May Have Use in Clinical Pathology Laboratories

The study found that a Robotic vapor-dispersing device kills and prevents spread of Drug-Resistant Organisms in high-risk patients by 64%

There is a new technology for disinfecting healthcare facilities that is likely to be useful for clinical laboratories and anatomic pathology groups.

A team at Johns Hopkins University Hospital recently published a study about their institution’s use of hydrogen peroxide vapor to disinfect hospital rooms.

The study was conducted over two and one-half years and involved hospital rooms used by thousands of patients. The goal of this study was to verify the effectiveness of a new robot-like device, known as Bioquell Q-10. This system disperses a hydrogen peroxide vapor to disinfect hospital rooms and was described in a news release issued by Baltimore-based Johns Hopkins University Hospital. (more…)

;